These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 18611716)

  • 21. [In vitro activity of ampicillin and ampicillin-sulbactam on diverse bacteria].
    Trucco O; Prado V; Mollinedo E; Cordoves A
    Rev Med Chil; 1989 Jul; 117(7):747-54. PubMed ID: 2519428
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In-hospital anaerobic susceptibility testing: an aid to formulary decision making.
    Lebar WD; Moody SB; Burnakis TG
    Hosp Formul; 1990 Jul; 25(7):746-8, 750-1. PubMed ID: 10105471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ampicillin and ampicillin-sulbactam dilution tests with mixed cultures of Bacteroides fragilis, Escherichia coli and Enterococcus.
    Heilmann F
    Infection; 1993; 21(3):187-90. PubMed ID: 8365818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro activities of colistin and ampicillin/sulbactam against Acinetobacter baumannii.
    Punpanich W; Munsrichoom A; Srisarang S; Treeratweeraphong V
    J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S95-100. PubMed ID: 22043760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro activity of sulbactam plus ampicillin against hospital isolates of coagulase-negative staphylococci and Acinetobacter species.
    Frank U; Daschner FD
    Infection; 1989; 17(4):272-4. PubMed ID: 2767773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam.
    Sader HS; Tosin I; Sejas L; Miranda E
    Braz J Infect Dis; 2000 Feb; 4(1):22-8. PubMed ID: 10788842
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative efficacy of cefoperazone, cefoperazone plus sulbactam, ciprofloxacin, clindamycin, metronidazole, and penicillin G against anaerobic bacteria in an animal model.
    Moody JA; Fasching CE; Sinn LM; Gerding DN; Peterson LR
    J Lab Clin Med; 1990 Feb; 115(2):190-5. PubMed ID: 1967626
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lessons learned from the anaerobe survey: historical perspective and review of the most recent data (2005-2007).
    Snydman DR; Jacobus NV; McDermott LA; Golan Y; Hecht DW; Goldstein EJ; Harrell L; Jenkins S; Newton D; Pierson C; Rihs JD; Yu VL; Venezia R; Finegold SM; Rosenblatt JE; Gorbach SL
    Clin Infect Dis; 2010 Jan; 50 Suppl 1():S26-33. PubMed ID: 20067390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Antimicrobial activity of ornidazole and 6 other antibiotics against anaerobic bacteria].
    Alados JC; Martínez-Brocal A; Miranda C; Rojo MD; García V; Domínguez MC; de la Rosa M
    Enferm Infecc Microbiol Clin; 1991 Apr; 9(4):219-22. PubMed ID: 1863621
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of sulbactam in an in vitro model of mixed aerobic/anaerobic infections.
    Heizmann WR; Heilmann F; Egeler B; Werner H
    Infection; 1990; 18(2):117-21. PubMed ID: 2332245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic interchange of ampicillin-sulbactam for cefoxitin.
    Lawrenz CA; Cole P; Theodorou A; Cook RL; Bermann L
    Am J Hosp Pharm; 1991 Oct; 48(10):2150-4. PubMed ID: 1781470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antimicrobial susceptibility of anaerobic bacteria in Auckland 1987-90.
    Henderson G; Garner J; Morris A
    N Z Med J; 1992 Jan; 105(926):11-2. PubMed ID: 1549266
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ampicillin/sulbactam and cefoxitin in the treatment of cutaneous and other soft-tissue abscesses in patients with or without histories of injection drug abuse.
    Talan DA; Summanen PH; Finegold SM
    Clin Infect Dis; 2000 Aug; 31(2):464-71. PubMed ID: 10987706
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro activity of ramoplanin and comparator drugs against anaerobic intestinal bacteria from the perspective of potential utility in pathology involving bowel flora.
    Finegold SM; John SS; Vu AW; Li CM; Molitoris D; Song Y; Liu C; Wexler HM
    Anaerobe; 2004 Aug; 10(4):205-11. PubMed ID: 16701520
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of cefoxitin, cefotetan and the combination of ampicillin with sulbactam in the therapy of polymicrobial infection in mice.
    Brook I
    J Antimicrob Chemother; 1994 Nov; 34(5):791-6. PubMed ID: 7706175
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Single-agent therapy for acute pelvic inflammatory disease: sulbactam/ampicillin versus cefoxitin.
    Hemsell DL; Bawdon RE; Hemsell PG; Nobles BJ; Heard MC
    J Int Med Res; 1990; 18 Suppl 4():85D-89D. PubMed ID: 2282973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of ampicillin/sulbactam in patients undergoing colorectal surgery: measurements in serum, the colonic wall and in tissue at the incision site.
    Wenzel M; Wildfeuer A; Gutsche F
    Int J Antimicrob Agents; 1996 Apr; 6 Suppl():S35-9. PubMed ID: 18611718
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ampicillin/Sulbactam vs. Cefoxitin for the treatment of pelvic inflammatory disease.
    Jemsek JG; Harrison F
    Infect Dis Obstet Gynecol; 1997; 5(5):319-25. PubMed ID: 18476179
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alterations in the human oropharyngeal microflora related to therapy with aztreonam, moxalactam and ampicillin plus sulbactam.
    Heimdahl A; Kager L; Nord CE
    Scand J Infect Dis; 1986; 18(1):49-52. PubMed ID: 3008310
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inpatient treatment for uncomplicated and complicated acute pelvic inflammatory disease: ampicillin/sulbactam vs. Cefoxitin.
    Hemsell DL; Wendel GD; Hemsell PG; Heard ML; Nobles BJ
    Infect Dis Obstet Gynecol; 1993; 1(3):123-9. PubMed ID: 18475331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.